Submit Deal
All Dealmakers
Similar Dealmakers
Partner at Gibson Dunn & Crutcher
Lawyer
San Francisco
Share Profile
Deal Bio
Market Context
Awards
Back to top
All rights reserved. Copyright © 2025 Datasite
Expertise (49)
Key Relationships
Sort
Target: COVETRUS (SCIL ANIMAL CARE BUSINESS)
Bidder: HESKA CORPORATION
5 Service Providers
7 Dealmakers
£ 89 M
Value
Target: ZYLA LIFE SCIENCES
Bidder: ASSERTIO THERAPEUTICS
7 Service Providers
34 Dealmakers
£ 85 M
Target: SHATTUCK LABS
Bidder: HATTERAS VENTURE PARTNERS
12 Service Providers
15 Dealmakers
£ 94 M
Target: TETRAPHASE PHARMACEUTICALS
Bidder: LA JOLLA PHARMACEUTICAL
6 Service Providers
£ 47 M
Target: KIQ LLC
Bidder: UNUM THERAPEUTICS INC
13 Dealmakers
n/a
Target: ANELIXIS THERAPEUTICS
Bidder: NOVUS THERAPEUTICS
8 Service Providers
4 Dealmakers
Target: QUELLIS BIOSCIENCES
Bidder: CATABASIS PHARMACEUTICALS
9 Service Providers
23 Dealmakers
Target: MOONLAKE IMMUNOTHERAPEUTICS
Bidder: BVF PARTNERS
25 Service Providers
44 Dealmakers
£ 169 M
Target: ORTHO CLINICAL DIAGNOSTICS
Bidder: QUIDEL CORPORATION
61 Dealmakers
£ 6.01 B
Target: ATARA BIOTHERAPEUTICS (T-CELL FACILITY)
Bidder: FUJIFILM HOLDINGS CORP
8 Dealmakers
£ 74 M
Target: LA JOLLA PHARMACEUTICAL
Bidder: INNOVIVA INC
12 Dealmakers
£ 124 M
Target: PALAMEDRIX
Bidder: SOMALOGIC
£ 43 M
Target: ENLIVEN THERAPEUTICS
Bidder: IMARA
11 Service Providers
41 Dealmakers
Target: APOGEE THERAPEUTICS
Bidder: PERCEPTIVE ADVISORS LLC
3 Service Providers
3 Dealmakers
£ 122 M
Target: ALLURION TECHNOLOGIES
Bidder: COMPUTE HEALTH ACQUISITION CORP
13 Service Providers
14 Dealmakers
£ 414 M
Target: JOUNCE THERAPEUTICS
Bidder: CONCENTRA HEALTH SERVICES
11 Dealmakers
£ 78 M
Target: MILESTONE PHARMACEUTICALS
Bidder: RTW INVESTMENTS
£ 100 M
Target: DIANTHUS THERAPEUTICS
Bidder: MAGENTA THERAPEUTICS
Target: CTI BIOPHARMA
Bidder: SWEDISH ORPHAN BIOVITRUM AB (SOBI)
16 Service Providers
76 Dealmakers
£ 1.35 B
Target: CULLGEN
Bidder: ASTRAZENECA-CICC VENTURE CAPITAL PARTNERSHIP
2 Service Providers
£ 32 M
Target: COHBAR INC
Bidder: MORPHOGENESIS INC
£ 12 M
Target: SPYRE THERAPEUTICS
Bidder: AEGLEA BIOTHERAPEUTICS
17 Dealmakers
£ 86 M
Target: NEOLEUKIN THERAPEUTICS
Bidder: NEUROGENE INC
6 Dealmakers
£ 282 M
Target: VERASTEM
£ 48 M
Target: RAIN ONCOLOGY INC
Bidder: PATHOS AI
33 Dealmakers
Target: COGENT BIOSCIENCES
Bidder: REDMILE GROUP
£ 284 M
Target: ALTRUBIO
10 Dealmakers
£ 177 M
Target: EPYGENIX THERAPEUTICS
Bidder: HARMONY BIOSCIENCES LLC
5 Dealmakers
£ 542 M
Target: ARCA BIOPHARMA
Bidder: ORUKA THERAPEUTICS
Target: CIDARA THERAPEUTICS
Bidder: RA CAPITAL MANAGEMENT
£ 193 M
Target: THIRD ARC BIO
Bidder: VIDA VENTURES
£ 127 M
Target: AMBROSIA BIOSCIENCES
Target: CRESCENT BIOPHARMA INC
Bidder: GLYCOMIMETICS
Target: AEROVATE THERAPEUTICS
Bidder: VENROCK HEALTHCARE CAPITAL PARTNERS
Target: MARINUS PHARMACEUTICALS
Bidder: IMMEDICA PHARMA AB
£ 120 M
Target: ALLAKOS INC
Bidder: CONCENTRA BIOSCIENCES
£ 22 M
Target: KRONOS BIO
£ 26 M
Target: ELEVATION ONCOLOGY
4 Service Providers
£ 19 M
Target: IGM BIOSCIENCES
£ 59 M
Target: CONCERT PHARMACEUTICALS
Target: CARGO THERAPEUTICS
27 Dealmakers
£ 159 M
Target: ESSA PHARMA
Bidder: XENOTHERAPEUTICS INC
Target: ADAPTIMMUNE [FOUR CELL THERAPY ASSETS]
Bidder: US WORLDMEDS
£ 40 M
Target: ITEOS THERAPEUTICS SA
£ 176 M
Target: LAVA THERAPEUTICS
Bidder: XOMA ROYALTY
43 Dealmakers
£ 24 M
Target: TURNSTONE BIOLOGICS
16 Dealmakers
Target: HILLEVAX INC
24 Dealmakers
Target: MURAL ONCOLOGY
Bidder: XRA 5 CORP
Target: 89BIO INC
Bidder: ROCHE HOLDINGS AG
22 Dealmakers
£ 2.56 B
